🕵️ Silexion Therapeutics Corp ($SLXN)
SEC insider & ownership activity, last 12 months · CIK 2022416 · every row links its SEC filing
Over the last 12 months insiders sold $31K with no open-market buying against it. Shirvan Mitchell sold $31K in discretionary trades (Mar). Moringa Sponsor, LP trimmed 33.0% → 10.6%; Ilan Levin trimmed 33.0% → 10.6%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $31K (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Shirvan Mitchell | 0 | – | 1 | $31K | Mar 26, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Moringa Partners Ltd | 10.6% | 13D | Jun 14, 2026 | filing ↗ | |
| Moringa Sponsor, LP | 10.6% | 13D | Jun 14, 2026 | filing ↗ | |
| Ilan Levin | 10.6% | 13D | Jun 14, 2026 | filing ↗ | |
| Intracoastal Capital, LLC | 10.0% | 13G | Sep 17, 2025 | filing ↗ | |
| Mitchell P. Kopin | 9.4% | 13G | Feb 13, 2026 | filing ↗ | |
| Daniel B. Asher | 9.4% | 13G | Feb 13, 2026 | filing ↗ | |
| Intracoastal Capital LLC | 9.4% | 13G | Feb 13, 2026 | filing ↗ | |
| Lincoln Alternative Strategies LLC | 6.2% | 13G | Sep 15, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jul 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 29, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jul 21, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jul 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 21, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | May 29, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | May 29, 2026 | filing ↗ |
| Other events (8.01) | May 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 29, 2026 | filing ↗ |
| Other events (8.01) | May 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 26, 2026 | filing ↗ |
| Earnings (2.02) | May 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 18, 2026 | filing ↗ |
| Material agreement (1.01) | May 15, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | May 5, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 28, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 24, 2026 | filing ↗ |
| Shareholder vote (5.07) | Mar 23, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 3, 2026 | filing ↗ |